PL2550535T3 - HbF A1M JAKO MARKERY WCZESNEGO STADIUM DLA STANU PRZEDRZUCAWKOWEGO - Google Patents

HbF A1M JAKO MARKERY WCZESNEGO STADIUM DLA STANU PRZEDRZUCAWKOWEGO

Info

Publication number
PL2550535T3
PL2550535T3 PL11710137T PL11710137T PL2550535T3 PL 2550535 T3 PL2550535 T3 PL 2550535T3 PL 11710137 T PL11710137 T PL 11710137T PL 11710137 T PL11710137 T PL 11710137T PL 2550535 T3 PL2550535 T3 PL 2550535T3
Authority
PL
Poland
Prior art keywords
hbf
preeclampsia
early stage
stage markers
markers
Prior art date
Application number
PL11710137T
Other languages
English (en)
Inventor
Bo Akerström
Magnus Olsson
Stefan Hansson
Original Assignee
Preelumina Diagnostics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Preelumina Diagnostics Ab filed Critical Preelumina Diagnostics Ab
Publication of PL2550535T3 publication Critical patent/PL2550535T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Measuring Temperature Or Quantity Of Heat (AREA)
PL11710137T 2010-03-24 2011-03-24 HbF A1M JAKO MARKERY WCZESNEGO STADIUM DLA STANU PRZEDRZUCAWKOWEGO PL2550535T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201000245 2010-03-24
PCT/EP2011/001458 WO2011116958A1 (en) 2010-03-24 2011-03-24 Hbf and a1m as early stage markers for preeclampsia
EP20110710137 EP2550535B1 (en) 2010-03-24 2011-03-24 Hbf and a1m as early stage markers for preeclampsia

Publications (1)

Publication Number Publication Date
PL2550535T3 true PL2550535T3 (pl) 2015-09-30

Family

ID=42829834

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11710137T PL2550535T3 (pl) 2010-03-24 2011-03-24 HbF A1M JAKO MARKERY WCZESNEGO STADIUM DLA STANU PRZEDRZUCAWKOWEGO

Country Status (19)

Country Link
US (1) US20130122529A1 (pl)
EP (1) EP2550535B1 (pl)
JP (1) JP5926722B2 (pl)
KR (1) KR20130012023A (pl)
CN (1) CN102906568B (pl)
AU (1) AU2011231982B2 (pl)
BR (1) BR112012024175A2 (pl)
CA (1) CA2794021C (pl)
DK (1) DK2550535T3 (pl)
EA (1) EA024188B1 (pl)
ES (1) ES2543171T3 (pl)
HR (1) HRP20150802T1 (pl)
HU (1) HUE027719T2 (pl)
MX (1) MX2012011007A (pl)
NZ (1) NZ602733A (pl)
PL (1) PL2550535T3 (pl)
PT (1) PT2550535E (pl)
WO (1) WO2011116958A1 (pl)
ZA (1) ZA201207902B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5604111B2 (ja) 2007-02-12 2014-10-08 エー1エム ファーマ エービー 子癇前症の診断及び治療
RU2568891C1 (ru) * 2014-08-28 2015-11-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии на основе комбинаций генов цитокинов
RU2568893C1 (ru) * 2014-09-04 2015-11-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин с неотягощенной наследственностью
JP2016173366A (ja) 2015-03-16 2016-09-29 エー1エム ファーマ エービーA1M Pharma AB 子癇前症のバイオマーカー
KR102345905B1 (ko) 2015-07-30 2021-12-30 삼성전자주식회사 분광기의 반복 재현성 검증 장치 및 방법, 스펙트럼 데이터 분석 장치
US20250147045A1 (en) * 2022-02-18 2025-05-08 Sera Prognostics, Inc. Biomarker panels and methods for predicting preeclampsia

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079171A (en) 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
US5238819A (en) 1988-12-14 1993-08-24 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5939272A (en) * 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5108898A (en) 1989-01-18 1992-04-28 Peters John H Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy
EP1322957B1 (en) * 2001-05-04 2009-08-12 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
WO2005093413A2 (en) 2004-03-22 2005-10-06 Yale University Diagnosis and treatment of preeclampsia
US20060105419A1 (en) * 2004-08-16 2006-05-18 Biosite, Inc. Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
WO2007030889A1 (en) * 2005-09-15 2007-03-22 Victor Voroteliak Method of diagnosing pre-eclampsia
US20080133141A1 (en) * 2005-12-22 2008-06-05 Frost Stephen J Weighted Scoring Methods and Use Thereof in Screening
GB0600916D0 (en) * 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
CA2641898A1 (en) * 2006-02-02 2007-08-09 Diagnostic Technologies Ltd. A method for determining the effectiveness of a treatment for preeclampsia
CN101517078A (zh) * 2006-05-31 2009-08-26 貝丝以色列女执事医疗中心 诊断和治疗妊娠并发症的方法
JP5604111B2 (ja) * 2007-02-12 2014-10-08 エー1エム ファーマ エービー 子癇前症の診断及び治療
WO2009108073A1 (en) * 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease

Also Published As

Publication number Publication date
MX2012011007A (es) 2013-03-20
US20130122529A1 (en) 2013-05-16
BR112012024175A2 (pt) 2016-07-05
ZA201207902B (en) 2014-03-26
HRP20150802T1 (xx) 2015-11-06
AU2011231982A1 (en) 2012-10-25
EA201290948A1 (ru) 2013-04-30
DK2550535T3 (en) 2015-07-27
JP2013522634A (ja) 2013-06-13
CA2794021C (en) 2018-03-13
ES2543171T3 (es) 2015-08-17
HUE027719T2 (en) 2016-10-28
KR20130012023A (ko) 2013-01-30
EP2550535B1 (en) 2015-05-06
PT2550535E (pt) 2015-09-07
AU2011231982B2 (en) 2014-02-20
CN102906568B (zh) 2014-11-12
HK1179694A1 (en) 2013-10-04
CN102906568A (zh) 2013-01-30
JP5926722B2 (ja) 2016-05-25
EP2550535A1 (en) 2013-01-30
EA024188B1 (ru) 2016-08-31
WO2011116958A1 (en) 2011-09-29
CA2794021A1 (en) 2011-09-29
NZ602733A (en) 2014-03-28

Similar Documents

Publication Publication Date Title
GB201016001D0 (en) Composition and method
ZA201206832B (en) Novel peptides and method for their preparation and use
IL224390B (en) Compositions and methods for targeted thermal modulation
EP2583269A4 (en) SYSTEMS AND METHOD FOR A LIGHT INDICATOR
EP2566930A4 (en) COOLING COMPOSITIONS AND METHODS
PL2566246T3 (pl) Sposób przełączania w oparciu o agregację nośnych
EP2657188A4 (en) FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME
PH12013500698A1 (en) Hair-mending compositions and associated methods
PL2385029T3 (pl) Kompozycje i sposób cementowania odwiertów
IL222576A0 (en) Fexofenadine-based composition and preparation process therefor
EP2646412A4 (en) SYNTHETIC ACID AND ASSOCIATED METHODS
ZA201303949B (en) Compounds and methods for skin repair
GB201003531D0 (en) Composition and method
ZA201207902B (en) Hbf and a1m as early stage markers for preeclampsia
GB201008364D0 (en) Composition and method
GB201018650D0 (en) Methods and compositions
GB201008843D0 (en) Method and composition
IL223436A (en) Methods for preparing tetranor - pgdm and tetranor - pgjm
ZA201108148B (en) Triazine-aryl-bis-indoles and process for preparation thereof
GB201020439D0 (en) Method and composition
GB201009508D0 (en) Composition and method
GB201001243D0 (en) Composition and method
GB201000750D0 (en) Crop-enhancing method and composition
GB201002240D0 (en) Composition and method
TWM387686U (en) Easy-to-peel-off self-adhesive weight-gaining patch